Major depressive disorder, single episode, severe without psychotic features
ICD-10 Code: F32.2 · Body Part: Head/Brain (TBI)
QME Evaluation Process
Psychiatric interview, PHQ-9, functional assessment, suicide risk evaluation. Chapter 14 impairment rating for severe psychiatric disorder.
Typical Impairment Rating
30-50% WPI
AMA Guides Edition
5th Edition
Common Treatments
Related Conditions
Body Part Guide
Head/Brain (TBI) Evaluation Guide
Impairment rating methods, common conditions, and QME evaluation protocols
QME Specialties for Major depressive disorder, single episode, severe without psychotic features
Find a QME Specialist
Browse QME-certified physicians who evaluate major depressive disorder, single episode, severe without psychotic features and related head/brain (tbi) conditions in California.
Browse Neurology Physicians →Frequently Asked Questions
What is Major depressive disorder, single episode, severe without psychotic features (F32.2)?
Major depressive disorder, single episode, severe without psychotic features is an ICD-10 diagnosis code (F32.2) classified under Psychiatric conditions. It affects the Head/Brain (TBI) and is commonly encountered in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.
How is F32.2 rated for impairment?
The typical whole person impairment (WPI) range for Major depressive disorder, single episode, severe without psychotic features is 30-50% WPI. The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.
What is the QME evaluation process for F32.2?
Psychiatric interview, PHQ-9, functional assessment, suicide risk evaluation. Chapter 14 impairment rating for severe psychiatric disorder.
What treatments are common for Major depressive disorder, single episode, severe without psychotic features?
Common treatments for Major depressive disorder, single episode, severe without psychotic features include Combination psychotherapy and medication, Intensive outpatient program, Hospitalization if indicated. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.